Skip to content

Opening book details…

Can I read Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma on EtoBox?

Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma by Tom Rosenberg; Kee Kiat Yeo; Audrey Mauguen; Sanda Alexandrescu; Sanjay P Prabhu; Jessica W Tsai; Seth Malinowski; Mrinal Joshirao; Karishma Parikh; Sameer Farouk Sait; Marc K Rosenblum; Jamal K Benhamida; George Michaiel; Hung N Tran; Sonika Dahiya; Kara Kachurak; Gregory K Friedman; Julie I Krystal; Michael A Huang; Ashley S Margol; Karen D Wright; Dolly Aguilera; Tobey J MacDonald; Susan N Chi; Matthias A Karajannis is a Medicine article available to read on EtoBox.

What is Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma about?

## Abstract ## Background The prognosis for patients with pediatric high-grade glioma (pHGG) is poor despite aggressive multimodal therapy. Objective responses to targeted therapy with BRAF inhibitors have been reported in some patients with recurrent BRAF-mutant pHGG but are rarely sustained. ## Methods We performed a retrospective, multi-institutional review of patients with BRAF-mutant pHGG treated with off-label BRAF +/– MEK inhibitors as part of their initial therapy. ## Results Nineteen patients were identified, with a median age of 11.7 years (range, 2.3–21.4). Histologic diagnoses included HGG (n = 6), glioblastoma (n = 3), anaplastic ganglioglioma (n = 4), diffuse midline glioma (n = 3), high-grade neuroepithelial tumor (n = 1), anaplastic astrocytoma (n = 1), and anaplastic astroblastoma (n = 1). Recurrent concomitant oncogenic alterations included CDKN2A/B loss, H3 K27M, as well as mutations in ATRX, EGFR, and TERT. Eight patients received BRAF inhibitor monotherapy. Eleven patients received combination therapy with BRAF and MEK inhibitors. Most patients tolerated long-term treatment well with no grade 4–5 toxicities. Objective and durable imaging responses were seen in

Who reads Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Tom Rosenberg; Kee Kiat Yeo; Audrey Mauguen; Sanda Alexandrescu; Sanjay P Prabhu; Jessica W Tsai; Seth Malinowski; Mrinal Joshirao; Karishma Parikh; Sameer Farouk Sait; Marc K Rosenblum; Jamal K Benhamida; George Michaiel; Hung N Tran; Sonika Dahiya; Kara Kachurak; Gregory K Friedman; Julie I Krystal; Michael A Huang; Ashley S Margol; Karen D Wright; Dolly Aguilera; Tobey J MacDonald; Susan N Chi; Matthias A Karajannis
Publisher
Oxford University Press (OUP)
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by Tom Rosenberg; Kee Kiat Yeo; Audrey Mauguen; Sanda Alexandrescu; Sanjay P Prabhu; Jessica W Tsai; Seth Malinowski; Mrinal Joshirao; Karishma Parikh; Sameer Farouk Sait; Marc K Rosenblum; Jamal K Benhamida; George Michaiel; Hung N Tran; Sonika Dahiya; Kara Kachurak; Gregory K Friedman; Julie I Krystal; Michael A Huang; Ashley S Margol; Karen D Wright; Dolly Aguilera; Tobey J MacDonald; Susan N Chi; Matthias A Karajannis

Browse all works by Tom Rosenberg; Kee Kiat Yeo; Audrey Mauguen; Sanda Alexandrescu; Sanjay P Prabhu; Jessica W Tsai; Seth Malinowski; Mrinal Joshirao; Karishma Parikh; Sameer Farouk Sait; Marc K Rosenblum; Jamal K Benhamida; George Michaiel; Hung N Tran; Sonika Dahiya; Kara Kachurak; Gregory K Friedman; Julie I Krystal; Michael A Huang; Ashley S Margol; Karen D Wright; Dolly Aguilera; Tobey J MacDonald; Susan N Chi; Matthias A Karajannis